天祥药业品牌怎么样 申请店铺

我要投票 天祥药业在兽药行业中的票数:565 更新时间:2026-01-03
天祥药业是哪个国家的品牌?「天祥药业」是 新乡天祥药业有限公司 旗下著名品牌。该品牌发源于河南省新乡市,由创始人秦向林在2005-01-13期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力天祥药业品牌出海!将品牌入驻外推网,定制天祥药业品牌推广信息,可以显著提高天祥药业产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

天祥药业怎么样

新乡天祥药业有限公司是由新乡市兽药研究所与美国Cronell University药学院共同投资1500万建立的集兽药研发、生产、销售、动物保健、科技服务为一体的企业。公司坐落于美丽的新乡市亢村工业园区,占地面积48000平方米,建筑面积22000平方米。公司在引进外资的同时,引进了设备与技术,现有“粉剂/散剂/预混剂、水针剂(含中药提取)、大容量注射液(含中药提取)、口服液(含中药提取)、消毒剂、颗粒剂(含中药提取)”八个剂型车间;饲料线有:饲料添加剂(粉剂、液态)和预混合饲料两条生产线,车间布局合理、设备优良、科技含量高,设计年产量值2亿元。

新乡天祥药业有限公司现有员工200余人,其高级兽医师、教授、副教授10人,中级技术人员68人,大专以上学历占88.6%。公司在技术上依托于美国加州国立大学、美国康奈大学兽医学院、德国国家科学院、中国农大、河南科技学院、郑州牧专各院校。公司注重科技研发。由新乡市兽药研究所挂帅,依托新乡市兽药制剂工程技术研究中心,由专业知识渊博和实践经验丰富的药理学、病理学、药剂学的专家们组成一支实力强大的科研队伍,本着“以产品质量为农户服务,以科学技术为兽医创名”的产品理念。

新乡天祥药业有限公司引进了美国的企业管理理念,拥有一支经验丰富、技术精湛的技术服务团队和高学历、高素质、年轻化的营销团队,现具有完善的营销管理体系,公司现有兽药事业部、禽药事业部、生物科技事业部、天祥兽医院四个销售团队,以优质的产品、新的管理、专业的团队、技术精湛的售后服务团队,使我部的产品畅销在全国各地。

天祥人本着“待人以诚信、人不欺我”“待事以诚信、事无不成”的原则,愿与社会各界朋友携手共进,全心全意专注于动物保健事业的发展。


Xinxiang Tianxiang Pharmaceutical Co., Ltd. is an enterprise invested by Xinxiang Institute of veterinary medicine and cronell University College of pharmacy in the United States with a total investment of 15 million yuan, integrating the R & D, production, sales, animal health care and scientific and technological services of veterinary medicine. The company is located in the beautiful industrial park of Kangcun, Xinxiang City, covering an area of 48000 square meters and a building area of 22000 square meters. At the same time of introducing foreign investment, the company has introduced equipment and technology, and now there are eight dosage forms workshops of "powder / powder / premix, water injection (including Chinese medicine extraction), large volume injection (including Chinese medicine extraction), oral liquid (including Chinese medicine extraction), disinfectant, granule (including Chinese medicine extraction)"; the feed line includes: feed additive (powder, liquid) and premixed feed Production line, reasonable workshop layout, excellent equipment, high technology content, design annual output value of 200 million yuan. Xinxiang Tianxiang Pharmaceutical Co., Ltd. has more than 200 employees, including 10 senior veterinary doctors, professors and associate professors, 68 middle-level technicians, accounting for 88.6% of the total. The company relies on the National University of California, the school of veterinary medicine, the National Academy of Sciences, China Agricultural University, Henan University of science and technology, Zhengzhou pastoral college. The company pays attention to scientific research and development. Under the leadership of Xinxiang Veterinary Medicine Research Institute, relying on Xinxiang veterinary medicine engineering technology research center, a powerful scientific research team is composed of experts with profound professional knowledge and rich practical experience in pharmacology, pathology and pharmaceutics. It is based on the product concept of "serving farmers with product quality and creating famous veterinarians with science and technology". Xinxiang Tianxiang Pharmaceutical Co., Ltd. has introduced the enterprise management concept of the United States. It has an experienced and skilled technical service team and a highly educated, high-quality and young marketing team. Now it has a perfect marketing management system. The company has four sales teams, namely veterinary medicine business department, avian medicine business department, biotechnology business department and Tianxiang veterinary hospital, with high-quality products The new management, professional team and skilled after-sales service team make our products sell well all over the country. Based on the principle of "treating people with integrity, people don't deceive me" and "treating things with integrity, everything can be done", Tianxiang people are willing to work together with friends from all walks of life to focus on the development of animal health care.

本文链接: https://brand.waitui.com/472991d3b.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

印度政府批准电子元件制造计划下的投资金额为4186.3亿卢比

印度政府批准电子元件制造计划下的投资金额为4186.3亿卢比。(财联社)

15分钟前

分析师:三星SDI或将持续亏损直至2026年底

NH Investment & Securities以Ju Min-woo为首的分析师表示,三星SDI在2025年第四财季因美国电动汽车需求疲软而录得大于预期的亏损后,可能会持续亏损直至2026年底。这些分析师表示,由于在欧洲的电动汽车电池市场份额不断下滑,这家韩国电池制造商可能比竞争对手受到更大冲击。NH Investment & Securities预计,该公司第四财季将录得3,387亿韩元的营业亏损,而市场平均预期为亏损2,690亿韩元,并预计其2025年年度亏损为1.765万亿韩元。NH Investment & Securities预测,该公司2026年的营业亏损可能收窄至9,670亿韩元。(新浪财经)

15分钟前

葡萄牙12月特斯拉新车注册量同比下降12.7%,2025年累计下降22.3%

据葡萄牙汽车协会(ACAP),葡萄牙12月特斯拉新车注册量同比下降12.7%,2025年累计下降22.3%。(财联社)

15分钟前

元旦假期首日,全社会跨区域人员流动量超2亿人次

2026年1月1日,全社会跨区域人员流动量20747.5万人次,环比下降0.1%,同比增长20.3%。(央视新闻)

15分钟前

挪威2025年新车销量的96%为电动汽车

上周五的官方数据显示,去年在挪威注册的几乎所有新车都是纯电动汽车,其中特斯拉的销量更是一路飙升,使这个北欧国家在逐步淘汰汽油和柴油动力汽车方面巩固了全球领先地位。在税收优惠政策的推动下,2025年注册的所有新车中有95.9%是电动汽车,12月份这一数字接近98%。挪威道路联合会(OFV)的数据显示,这一年度数字高于2024年的88.9%。OFV称,挪威今年登记的新车数量达到创纪录的179549辆,比2024年增长了40%。(新浪财经)

15分钟前

本页详细列出关于天祥药业的品牌信息,含品牌所属公司介绍,天祥药业所处行业的品牌地位及优势。
咨询